Afinitor

In the US, Afinitor (everolimus systemic) is a member of the following drug classes: mTOR inhibitors, selective immunosuppressants and is used to treat Brain Tumor, Pancreatic Cancer and Renal Cell Carcinoma.

US matches:

• Afinitor

Ingredient matches for Afinitor

Everolimus

Everolimus is reported as an ingredient of Afinitor in the following countries:

• Australia


• Finland


• France


• Germany


• Greece


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search